NSETrading Window26 Jun 2026 · 26 Jun 2026, 04:53 pm
Trading Window
Suven Life Sciences Limited · SUVEN
✦ AI SummaryResults
Suven Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in securities of the Company will remain closed from July 1, 2026, till the end of 48 hours after the declaration of un-audited Financial Results for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Suven Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
SUVEN_26062026165241_TWSuven26062026.pdf
View document text
CSD/BSE&NSE/TW/2026-27
Date: 26th June, 2026
To To
The General Manager The Manager
Department of Corporate Services Listing Department
BSE Limited National Stock Exchange of India Limited
25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex
Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 530239 Scrip Symbol: SUVEN
Dear Sir/Madam,
Sub: Intimation of Closure of Trading Window
Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading)
Regulations, 2015 and the Company’s Code of Conduct to regulate, monitor and report
trading of designated persons, the ‘Trading Window’ for dealing in securities of the
Company for all the designated persons and their immediate relatives, Connected
Persons (including their relatives) as covered under the said code shall remain close
with effect from July 1, 2026, till the end of 48 hours after the declaration of un-audited
Financial Results for the quarter ended June 30, 2026.
Accordingly, all Designated Persons of the Company are being advised not to trade in
the securities of the Company during the aforesaid period of closure of the Trading
Window.
Please note that the date of the Board Meeting to be held for consideration of
un-audited financial results of the Company for quarter ended June 30, 2026, shall be
communicated in due course.
This is for your information and records.
Thanking you,
Yours faithfully,
For Suven Life Sciences Limited
K. Sangeetha Laxmi
Company Secretary & Compliance Officer
Suven Life Sciences Limited
Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7
Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713
Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com